Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review
- PMID: 36970110
- PMCID: PMC10037739
- DOI: 10.1177/17588359231161418
Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review
Abstract
Many patients with cancer search for and use alternative and complementary treatments, aiming to improve the effectiveness of their anticancer treatment and a reduction in treatment-associated side effects. Short-term fasting (STF) and fasting mimicking diets (FMDs) are among the most commonly used dietary interventions. In recent years, different trials have reported the promising results of dietary interventions in combination with chemotherapy, in terms of slowing down tumor growth and reduction in chemotherapy-related side effects. In this narrative review, we identify and describe the current evidence about feasibility and effects of STF and FMDs in cancer patients receiving chemotherapy. The studies that examined the effects of STF when combined with chemotherapy suggest potential benefits regarding reduction in side effects and improved quality of life. We also conclude with a list of well-designed studies that are still recruiting patients, examining the long-term effects of STF.
Keywords: chemotherapy; fasting mimicking diets; short-term fasting.
© The Author(s), 2023.
Conflict of interest statement
Hanneke W. M. van Laarhoven: Consultant or advisory role: Amphera, AstraZeneca, Beigene, BMS, Daiichy-Sankyo, Dragonfly, Eli Lilly, MSD, Nordic Pharma, Servier Research funding and/or medication supply: Bayer, BMS, Celgene, Janssen, Incyte, Eli Lilly, MSD, Nordic Pharma, Philips, Roche, Servier Speaker role: Astellas, Benecke, Daiichy-Sankyo, JAAP, Medtalks, Novartis, Travel Congress Management B.V.
References
-
- Huebner J, Prott FJ, Micke O, et al.. Online survey of cancer patients on complementary and alternative medicine. Oncol Res Treat 2014; 37: 304–308. - PubMed
-
- Molassiotis A, Fernandez-Ortega P, Pud D, et al.. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16: 655–663. - PubMed
-
- Clifton KK, Ma CX, Fontana L, et al.. Intermittent fasting in the prevention and treatment of cancer. CA Cancer J Clin 2021; 71: 527–546. - PubMed
-
- Tinsley GM, La Bounty PM. Effects of intermittent fasting on body composition and clinical health markers in humans. Nutr Rev 2015; 73: 661–674. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
